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1. Introduction
  Ulcerative colitis (UC) is a non-specific chronic 
inflammatory disease in rectum and colon. According to the 
statistics, the number of UC inpatients increased by 3 times 
in recent 10 years. It tends to occur in proximal section 
and even spreads to whole colon, which always leads to 
diarrhea, bellyache and mucous bloody stool. The disease 
situation is always repeated. One of severe complications 
of UC is the UC related colorectal cancer (UCRCC), which 
has a strong impact on life quality and longevity of 
patients. Presently, it has been accepted that the UC and 
carcinogenesis are related to abnormal immunomodulation 
of intestinal mucous membrane, constant enteral infection, 
and barrier injury of intestinal mucous membrane, genetics 
and environmental factors. MicroRNA is involved in the 
post-transcriptional regulation of genes and affects the 
growth and metabolism of cells. To investigate the roles of 
microRNA in UC and UCRCC, we detected its expression in 
mice with UC and UCRCC. 
  
2. Materials and methods
2.1. Mice
  Eighty Balc/c mice with the age of 6-8 weeks and weight 
of 22-30 g were purchased from Guangdong Medical 
Objective: To investigate the differential expression of microRNA (miRNA) in colon between 
ulcerative colitis (UC) and ulcerative colitis related colorectal cancer (UCRCC). Methods: An 
UC mouse model was built by dextran sodium sulfate, and an UCRCC mouse model by dextran 
sodium sulfate and 1,2-diformylhydrazine. RNAs were extracted from the colon, purified and 
hybridized with fluorescence-labeled miRNA oligonucleotide gene chip. Real-time fluorescence 
quantitative PCR was used to verify the expression variation of miRNA. SAM was employed for the 
data analysis. Results: The up-regulated miRNAs in colon cancer included has-miR-194, has-
miR-215, has-miR-93, has-miR-192, has-miR-92a, has-miR-29b, and has-miR-20a (median 
false discovery rate<5%), while the down-regulated miRNAs were has-miR-1231, has-miR-195, 
has-miR-143, and has-miR-145 (median false discovery rate<5%). Conclusions: Significant 
differential expression of miRNA was found between the UC mouse and UCRCC mouse, which 
may be related to the onset, erosion and transfer of colorectal cancer.
Yong-Gang Tan et al./Asian Pacific Journal of Tropical Medicine (2013)972-976 973
Laboratory Animal Center. They were bred in SPF grade 
rat/mouse breeding room and received 1 week of adaptive 
breeding under the constant humidity and temperature 
before the experiment.
2.2. Establishment of animal models and sample preparation
  The mice were randomly divided into control group (n=20), 
UC group (n=30) and colorectal cancer group (n=30). The 
inflammatory agent dextran sodium sulfate (DSS; Sigma-
Aldrich, USA) was adopted to induce the mouse model of 
chronic UC. After 1 week of freely feeding 35 g/L DSS, the 
mice received the intraperitoneal injection of physiological 
saline and 2 weeks of normal water drinking. This cycle 
cost 3 weeks and three cycles were used to establish the 
UC model. The UCRCC model was established in the same 
way, except that the mice received the intraperitoneal 
injection of 1,2-diformylhydrazine (DMH; Sigma-Aldrich) 
at a dose of 20 mg/kg after 1 week intake of DSS. The mice 
in the control group had free access to water and were 
intraperitoneally injected with physiological saline. After 
9 week induction, the murine status, stools and survival 
were observed and the disease activity index (DAI) was 
recorded according to their weight, stools and occult blood. 
The scoring standard is as follows: 1 point for the weight 
loss of 1%-5%, 2 points for 5%-10%, 3 points for 10%-15%, 
and 4 points for >15%; 1-2 points for the pale stool and 3-4 
points for the loose stool; 1-2 points for the occult blood 
and 3-4 points for macroscopic bloody stool. After the mice 
were killed by cervical dislocation and laparotomized, the 
segment from ileocecum to colon of anus was dissociated 
and longitudinally dissected. The patulous intestinal cavity 
was then cleaned with physiological saline and cut into 
two parts. One was immediately transferred into liquid 
nitrogen and then stored in a refrigerator at -80 曟 for mRNA 
detection, and the other one was fixed by formaldehyde for 
histopathological observation.
2.3. Total RNA extraction and chip hybridization
  The samples were milled into powder, and ion-exchange 
column adsorptive process was adopted to extract total 
RNA using mirVanaTM RNA isolation kit (Ambion). Then 
the concentration and purity of the total RNA were detected 
using ultraviolet spectrophotometer and formaldehyde-
agarose gel electrophoresis, and the extract with A260/A280 of 
1.9-2.1 was qualified. One oligonucleotide was marked at 
the end of poly-A tail for fluorescence labeled connection. 
Through a microcirceulation pump, chip hybridization was 
performed using miRNA oligonucleotide gene chip kit. Then 
GeneChipR hybridization wash and stain kit (Affymetrix) was 
used for digital washing and treatment of staining signals, 
and data were obtained using the professional software 
miRNA QC tool. 
2.4. RT-PCR
  
  According to the results of miRNA microarray, some 
miRNAs with the differential expression was further 
detected by real-time quantitative PCR. The 5S rRNA was 
used as the reference gene, and about 80 nucleotide long 
cDNA was obtained. The upstream primer sequences are 
presented in Table 1. The downstream primer provided by 
the kit was used (5’-GCTGTCAACGATACGCTACGTAA-3’). 
PCR was performed using the following temperature profile: 
denaturalization at 95 曟 for 2 min, 40 cycles of 94 曟 for 
20 s, at 58 曟 for 20 s and 72 曟 for 30 s. After the reaction, 
the results were analyzed using the 2-吤吤CT equation. All 
primers were purchased from Shanghai Biotech Co., Ltd.
Table 1
Upstream primer sequences for differentially expressed miRNAs.
miRNAs Upstream primer sequence
has-miR-20a 5’-AAAGTGCTTATAGTGCAGGTAGAAAA-3’
has-miR-29b 5’-ACACTCCAGCTGGGTAGCACCATTTGAAATC-3’
has-miR-92a 5’-TGTCCCGGCCTGTAAAAA-3’
has-miR-93 5’-TGCTGTTCGTGCAGGTAGAA-3’
has-miR-143 5’-GAGATGAAGCACTGTAGCTCAAAA-3’
has-miR-145 5’-TTTTCCCAGGAATCCCTAAAA-3’
has-miR-192 5’-ACACTCCAGCTGGGCTGACCTATGAATTG-3’
has-miR-194 5’-ACACTCCAGCTGGGTGTAACAGCAACTCCA-3’
has-miR-195 5’-TAGCAGCACAGAAATATTGG-3’
has-miR-215 5’-ACACTCCAGCTGGGATGACCTATGAATTG-3’
has-miR-1231 5’-ACACTCCAGCTGGGGTGTCTGGGCGGAC-3’
2.5. Histopathological observation
  After the fixation with formaldehyde, the lesion part of 
distal colonic tissue was embedded by paraffin and cut into 
sections with the thickness of 4 毺m. Then the sections were 
stained by hematoxylin and eosin (HE) solution (Beijing 
Zhong Shan Golden Bridge Biological Technology) and 
observed under an optical microscope. 
2.6. Statistical analyses
  The microarray data analysis software for the significant 
difference was employed to analyze the differential 
expression of miRNA. The median false discovery rate 
(FDR) indicates the probability to cause the differential 
gene expression by accidental factors. FDR<0.05 means 
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the statistical significance for the differential expression of 
miRNA. The results of real-time fluorescence quantitative 
PCR were used for the statistical analysis on the differences 
of gene expression. P<0.05 was considered statistically 
significant.
 
3. Results
3.1. Comparison on DAI between the groups
  
  The mice in the control group had normal mental state and 
diet, no weight change, and no diarrhea or bloody stool. The 
DAI score of the control group was 0. Diarrhea began to occur 
after 3-4 days in the mice of the UC group, and all mice in 
this group suffered diarrhea, bloody stool or adhesion of 
loose/bloody stool to anus after 1 week. They were also faint, 
slouchy and disheveled. During the 2nd and 3rd cycles, they 
were careless and usually stayed still. The DAI score of the 
UC group was 18.2暲1.2, which was significantly higher than 
that of the control group (P<0.05). The mice in the colorectal 
cancer group also had similar manifestations as those in 
the UC group, but they were weaker during the 2nd and 3rd 
cycles. The DAI score of the colorectal cancer group was 
33.5暲1.4, which was significantly higher than that of the UC 
group (P<0.05). 
3.2. Comparison on histopathological changes between the 
groups
  As revealed by HE staining, the mice in the control 
group had complete and clear structure of mucous 
colonic epithelium, orderly arranged epithelia, and 
complete glandular organs. Obvious histopathological 
changes were observed in the mice of the UC group, as 
displayed by remarkably shortened colon, thickened and 
hardened intestinal wall, comprehensively congested and 
swollen intestinal mucosa, local erosion and hemorrhage, 
and distinct ulcerative regions. Moreover, large-area 
disappearance of mucosa, incomplete structure of most 
glandular organs, and wide infiltration of inflammatory cells 
also indicated the typical inflammatory responses in these 
mice. In the mice of the colorectal cancer group, tuberculum 
minus appeared in the colonic wall. In addition, thickened 
cavity, hardened wall, large-area disappearance of mucosa 
and incomplete structure of most glandular organs were 
also observed. No distinct changes were found in the small 
intestine. Colonic adenocarcinoma and senior dysplasia 
suggested typical carcinogenesis in these mice (Figure 1).
A B C
Figure 1. Histopathological changes in colon.
A. Control group; B. Ulcerative colitis group; C. Colorectal cancer 
group.
3.3. Effects of UCRCC on miRNA levels 
  According to the analysis of the miRNA chip results by 
SAM software, the miRNA levels in mucous membrane 
varied in the UC group, compared with those in the control 
group, but the FDRs were not significantly different between 
the two groups (Table 2). The miRNA levels in mucous 
membrane significantly varied in the colorectal cancer 
group, and the FDRs was significantly different from those 
in the control and UC groups (P<0.05) (Table 2). The levels of 
seven miRNAs were up-regulated significantly, including 
has-miR-194, has-miR-215, has-miR-93, has-miR-192, 
has-miR-92a, has-miR-29b, and has-miR-20a, while the 
levels of four miRNAs were down-regulated significantly, 
including has-miR-1231, has-miR-195, has-miR-143 and 
has-miR-145 (Table 3). The real-time quantitative PCR also 
confirmed the same results and demonstrated the reliability 
of the miRNA chip (Table 3). 
Table 2
Differential expression of miRNA between the groups as detected by 
RT-PCR.
miRNAs Control group Ulcerative colitis 
group
Colorectal cancer 
group
has-miR-194   7.6   7.7   8.6*吤
has-miR-215 11.5 11.7 13.1*吤
has- miR-192 14.0 14.3 16.3*吤
has-miR-93 14.3 14.7 17.5*吤
has-miR-29b 16.7 17.1 20.7*吤
has-miR-92a 10.9 11.3 12.5*吤
has-miR-20a 13.4 13.7 16.5*吤
has-miR-1231 18.6 18.3 13.0*吤
has-miR-195 14.5 14.3 10.6*吤
has-miR-143 16.5 16.2 13.5*吤
has-miR-145 22.5 22.0 18.4*吤
*P<0.05 vs. the control group; 吤P<0.05 vs. the ulcerative colitis group.
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Table 3 
Differential expression levels of miRNAs as detected by chip and RT-
PCR.
miRNAs RT-PCR Chip
Up-regulated miRNAs
  has-miR-194 3.32 3.26
  has-miR-215 3.56 4.33
  has-miR-192 7.64 6.84
  has-miR-93 1.83 1.54
  has-miR-29b 1.74 1.89
  has-miR-92a 1.58 1.56
  has-miR-20a 1.43 1.39
Down-regulated miRNAs
  has-miR-1231 0.69 0.75
  has-miR-195 0.56 0.53
  has-miR-143 0.52 0.48
  has-miR-145 0.57 0.58
The differential time in chip microarray is the ratio of standard value 
of UCRCC group to that of control group. The differential times in RT-
PCR were obtained using the 2-吤吤CT equation.
4. Discussion
   UC is a non-specific colorectal inflammation caused by 
unknown reasons. The pathological changes mainly occur 
in the mucous membrane and submucosa of colon, showing 
the continuous and diffuse distribution. The risk of UC 
carcinogenesis tends to be increased year by year. The 
possibility for patients with UC to suffer the colorectal cancer 
is 20-30 times higher than that for the general population[1]. 
The miRNA is a group of endogenous non-coding RNA with 
the length of 19-24 nucleotides. Its primary function is to 
complementarily pair with specific bases from mRNA of 
target gene and to negatively regulate the gene expression by 
degrading the target mRNA and restraining the translation of 
target mRNA[2,3]. Current researches have shown that miRNA 
is closely related to the growth development of animals and 
plants, cell differentiation and death, fat metabolism and 
some serious diseases in human[4-7]. As miRNA plays a 
regulatory role in gene expression, protein translation and 
occurrence of tumors, miRNA may be a possible oncogene 
or tumor suppressor gene. The miRNA expression profile 
in tissues or cells is thus of critical significance for the in-
depth researches to investigate the biological roles of miRNA 
in human diseases. 
  Depending on building the mouse model of ulcerative 
colitis and related colorectal cancer, this paper adopted 
miRNA expression profile microarray to detect the 
expression profile of miRNA in mucous membrane of mouse 
ulcerative colitis/normal large intestine and colorectal 
cancer/ulcerative colitis, and discuss the reliability of 
results of miRNA profile microarray.
  Experimental results showed that the mental state, 
activity and stool of mice in the control group were all 
normal, without situations of diarrhea or bloody stool. Mice 
in the ulcerative colitis group had the diarrhea, bloody 
stool or loose/bloody stool adhered to anus 3-5 days after 
establishing the model. The diarrhea was most serious 
in the 1st cycle. In the 2nd and 3rd cycles, the clinical 
manifestations of ulcerative colitis such as diarrhea were 
weakened, but the mental state became worse and the 
body gradually became thin. Mice in the colorectal cancer 
group had similar manifestations to ones in the ulcerative 
colitis group in the 1st cycle. But in the 2nd and 3rd cycles, 
manifestations of diarrhea, bloody stool or loose/bloody 
stool adhered to anus were more serious than ones in the 
ulcerative colitis group, and the weight loss was also faster. 
It indicated the smooth model building and it was confirmed 
by the histopathological analysis. The combined methods of 
DSS and DMH can build the ideal animal model of ulcerative 
colitis associated carcinogenesis and provide the important 
animal model for the further study on the mechanism of 
ulcerative colitis associated carcinogenesis.
  A great number of researches showed that there were 
abnormal expressions of miRNA in many human tumors[8-12].
According to our experimental results, the difference in 
miRNA was not significant between the ulcerative colitis 
group and control group; but there was significant change 
in miRNA in the colorectal cancer, where 7 miRNAs were 
significantly up-regulated, including has-miR-194, 
has-miR-215, has-miR-93, has-miR-192, has-miR-
92a, has-miR-29b, and has-miR-20a and 4 miRNAs 
were significantly down-regulated, including has-miR-
1231, has-miR-195, has-miR-143 and has-miR-145. 
Link et al[13] indicated the high expression of miR-92a in 
tissues of colorectal cancer, even in the stool of patients 
with colorectal cancer, and its increase in expression was 
reversely proportional to the survival period and prognosis, 
which was in line with results of this research. Wang et al[14] 
showed the low expression of miR-143 and miR-145 in 
colorectal cancer cells. The over-expression of miR-143 can 
also reduce the colony formation of colorectal cancer cells 
on soft agar culture medium[15], and miR-143 and miR-145 
were recognized as tumor suppressors[16]. Xu et al[17] drew 
the conclusion that the expression level of miR-195 was 
reversely proportional to the growth of colorectal cancer cells 
and its high expression could suppress the growth of cancer 
cells. Thus it can be regarded that the specific miRNA is 
closely related to the occurrence and pathologic process 
of colorectal cancer, which may provide new indictors for 
the diagnosis, treatment and prognosis of colorectal cancer. 
According to results of real-time fluorescent quantitative 
RT-PCR experiment, results of quantitative PCR detection 
was in line with the microarray results, which indicated 
that our experimental results were reliable. At present, 
researches show that miRNA microarray is characterized 
by high-throughput united detection, high detection 
efficiency and sensitivity and small sample size, which is 
significantly better than the traditional RNA detection. It 
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is a technology that can detect the expression of miRNA in 
cells or tissues under different physiological conditions and 
it will contribute to the researches on biological functions of 
miRNA[18].
  In conclusion, there was high expression of has-miR-
194, has-miR-215, has-miR-93, has-miR-192, has-miR-
92a, has-miR-29b and has-miR-20a, but low expression of 
has-miR-1231, has-miR-195, has-miR-143 and has-miR-
145 in the colorectal cancer group. A significant differential 
expression of miRNA could be found between intestinal 
mucosas of colorectal cancer   and ulcerative colitis, which 
indicated that these miRNAs might participate in the onset 
and migration of colorectal cancer. It’s worthy to take the 
further study on the molecular mechanism of miRNAs in 
colorectal cancer.
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